期刊文献+

PKD3上调前列腺癌细胞中PSA表达及机制 被引量:1

PKD3 contributes to up-regulation of prostate-specific antigen in prostate cancer cells
下载PDF
导出
摘要 目的研究蛋白激酶D3(PKD3)对前列腺癌细胞中前列腺特异性抗原(PSA)表达水平的影响及其机制,以期阐明PKD3在雄激素依赖的前列腺癌细胞增殖中的重要作用。方法首先,在LNCaP细胞中过表达PKD3并以双氢睾酮刺激,而后采用荧光定量PCR扩增PSA的cDNA并使用2-△△Ct方法比较其相对表达量的变化;其次,在HEK293细胞中,共转染PKD3的野生型质粒(或无激酶活性的突变型质粒)、AR的表达质粒、AR转录活性的报告质粒pMMTV-luc及内参照报告质粒pRL-SV40,并以双氢睾酮刺激后,以Promega的双报告基因分析试剂盒测定AR的转录活性。最后,利用共聚焦显微技术分析LNCaP细胞中内源性的PKD3和AR在有无双氢睾酮刺激时亚细胞定位的变化和可能的共定位。结果在LNCaP细胞中,过表达PKD3可明显升高双氢睾酮刺激时PSA的mRNA表达水平(P<0.001)。与之相符,在HEK293细胞中,过表达PKD3明显提高双氢睾酮刺激时AR的转录活性(P<0.001),而过表达无激酶活性的PKD3可部分降低AR的转录活性(P<0.01)。此外,LNCaP细胞中内源性的PKD3和AR在双氢睾酮刺激时均向核内转位并共定位于核内。结论 PKD3增强双氢睾酮刺激的前列腺癌细胞中AR的转录活性及上调PSA的表达,提示PKD3可能参与雄激素依赖的前列腺细胞的生长和恶性增殖。 Objective To investigate the role of PKD3 in prostate-specific antigen (PSA) expression regulation in androgen-dependent prostate cancer cells and explore the mechanism. Methods LNCaP cells containing low level of PKD3 were transfected with pEGFP-C2 or pEGFP-PKD3 plasmid followed by dihydrotestosterone (DHT) treatment, and PSA mRNA level was analyzed by RT-QPCR using 2-△△Ct method. Wild-type or kinase-dead PKD3 plasmids, human androgen receptor plasmid pSVAR0, pMMTV-luc of AR luciferase reporter and renilla luciferase reporter pRL-SV40 were cotransfected into HEK293 cells, and after treatment with DHT for 24 h, the cells were harvested and AR transcriptional activity were determined by dual-luciferase reporter assay. The subcellular localization of endogenous PKD3 and AR and their colocalization induced by DHT were observed by confocal microscopy. Results PSA mRNA level triggered by DHT was significantly increased by overexpression of pEGFP-PKD3 in LNCaP cells compared with that in pEGFP-C2 control cells (P〈0.001). AR transcription in response to DHT treatment was also significantly up-regulated by wild type PKD3 expression (P〈0.001), but partially down-regulated by kinase-dead PKD3 mutant (P〈0.01). Endogenous PKD3 and AR in LNCaP cells not only translocated from the cytoplasm to the nucleus, but also colocalized with each other after DHT stimulation. Conclusion Elevated AR transcriptional activity and enhanced expression of PSA induced by PKD3 in response to DHT treatment suggest that PKD3 contributes to the proliferation and malignant growth of androgen-dependent prostate cancer cells.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2010年第8期1779-1782,共4页 Journal of Southern Medical University
基金 国家自然科学基金(30973014) 教育部留学回国人员科研启动基金(K1010353)
关键词 蛋白激酶D3 雄激素受体 前列腺癌 前列腺特异性抗原 protein kinase D3 androgen receptor prostate cancer prostate-specific antigen
  • 相关文献

参考文献12

  • 1Taplin ME. Drug insight: role of the androgen receptor in the development and progression of prostate cancer [ J ]. Nat Clin Pract Oncol, 4(4): 236-44. 被引量:1
  • 2Wang QJ. PKD at the crossroads of DAG and PKC signaling [J ]. Trends Pharmacol Sci, 2006, 27(6): 317-23. 被引量:1
  • 3Rozengurt E, Rey O, Waldron RT. Protein kinase D signaling [ J ]. J Biol Chem, 2005, 280(14): 13205-208. 被引量:1
  • 4Jaggi M, Rao PS, Smith D J, et al. Protein kinase C mu is down-regulated in androgen-independent prostate cancer [J]. Biochem Biophys Res Commun ,2003, 307(2): 254-60. 被引量:1
  • 5Mak P, Jaggi M, Syed V, et al. Protein kinase D1 (PKD1) influences androgen receptor (AR) function in prostate cancer cells [J]. Biochem Biophys Res Commuo, 2008, 373(4): 618-23. 被引量:1
  • 6Chen J, Deng F, Singh SV, et al. Protein kinase D3 (PKD3) contributes to prostate cancer cell growth and survival through a PKCepsilon/PKD3 pathway downstream of Akt and ERK 1/2 [J]. Cancer Res, 2008, 68(10): 3844-53. 被引量:1
  • 7Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real -time quantitative PCR and the 2 ( - Delta Delta C (t) ) method[ J ]. Methods, 2001, 25(4): 402-08. 被引量:1
  • 8Vollmer RT, Montana GS. The dynamics of prostate-specific antigen after definitive radiation therapy for prostate cancer[J]. Clin Cancer Res, 1999,5(12): 4119-25. 被引量:1
  • 9Sissons GR, Clements R, Peeling WB, et al. Can serum prostatespecific antigen replace bone scintigraphy in the followup of metastatic prostatic cancer [J ]? Br J Radiol, 1992, 65(778): 861-64. 被引量:1
  • 10Truica CI, Byers S, Gelmann EP. Beta-catenin affects androgen receptor transcriptional activity and ligand specificity [J ]. Cancer Res, 2000, 60(17): 4709-13. 被引量:1

同被引文献14

  • 1何振辉,何太平,莫丽儿,梁念慈.白藜芦醇与半边旗二萜类化合物5F对活体血管生成的影响[J].实用医技杂志,2006,13(1):1-3. 被引量:5
  • 2Chen GG, Leung J, Liang NC, et al. Ent-ll(x-hydroxy- 15-oxo-kaur-16-en-19-oic-acid inhibits hepatocellular car- cinoma in vitro and in vivo via stabihzing IkB(x [ J]. Invest New Drugs, 2012, 30(6) :2210. 被引量:1
  • 3Li MY, Liang NC, Chen GG. Ent-11α-hydroxy-15-oxo-kaur- 16-en-19-oic-acid induces apoptosis of human malignant canc- er cells[J]. Curt Drug Targets, 2012, 13(14):1730. 被引量:1
  • 4Bocci G, Fioravanti A, Orlandi P, et al. Metronomic ceram- ide analogs inhibit angiogenesis in pancreatic cancer through up-regulation of caveolin-1 and thrombospondin-1 and down- regulation of cyclin D1 [J]. Neoplasia, 2012, 14(9):833. 被引量:1
  • 5Shibuya M. Vascular Endothelial Growth Factor (VEGF) and Its Receptor (VEGFR) Signaling in Angiogenesis: A Crucial Target for Anti- and Pro-Angiogenic Therapies [J]. Genes Cancer, 2011, 2(12): 1097. 被引量:1
  • 6Rastelli L, Valentino ML, Minderman MC binding peptide ( ST100, 059 ) can melanoma tumor growth and metastasis [J]. Int J Oncol, 2011, 39(2): 401. 被引量:1
  • 7Holmqvist K, Cross M J, Rolny C, et al. The adaptor pro- tein shb binds to tyrosine 1175 in vascular endothelial growth factor (VEGF) receptor-2 and regulates VEGF-de- pendent cellular migration [ J ]. J Biol Chem, 2004, 279 (21) : 22267. 被引量:1
  • 8Murakami M, Zheng Y, Hirashima M, et al. VEGFR1 tyrosine kinase signaling promotes lymphangiogenesis as well as angiogenesis indirectly via macrophage recruitment [J]. Arterioscler Thromb Vasc Biol, 2008, 28(4):658. 被引量:1
  • 9何太平,覃燕梅,莫丽儿,吴科锋,梁念慈.半边旗二萜类化合物5F对高转移卵巢癌HO-8910PM细胞中癌相关基因表达的影响[J].中国药理学通报,2008,24(1):117-122. 被引量:10
  • 10何太平,吴科锋,吕应年,龚先玲,George Gong Chen,梁念慈.半边旗二萜化合物5F对HO-8910PM细胞中Nr1d1表达的影响[J].中国中药杂志,2009,34(10):1268-1271. 被引量:5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部